US$ 20.40
glp-1 news september 26 2025 Weight-Loss Drug Demonstration Begins July 2026 2025 dominates for GLP-1 trial
Description
Youre close, but I think the comparison undersells the shift

NICE also recommends semaglutide for obesity only within specialist weight management services, alongside diet and physical activity support

Dual GIP/GLP-1 receptor agonists: New advances for treating type-2 diabetes

Additionally, they might help with sleep apnea and improve overall well-being

We are also seeing an ncrease in patient consultations linked to GLP-1 drugs
It's important to recognize that total fluid intake includes water from all sources: plain water, coffee, tea, other beverages, and water-rich foods like cucumbers, watermelon, and soups
